Population-based study of hepatitis C virus infection and hepatocellular carcinoma in western Japan

Hepatology Research

Volumn 23, Issue 1, 2002, Pages 18-24

  Wada, Ikuko ^a   Hara, Toshiya ^a   Kajihara, Susumu ^a   Mizuta, Toshihiko ^a   Ozaki, Iwata ^a   Hisatomi, Akitaka ^a   Yamamoto, Kyosuke ^a  

^a Saga Medical School   (Japan)

Author keywords

Correlation study; Hepatitis C virus; Hepatitis C virus antibody; Hepatocellular carcinoma; Japan; Mortality; Population based study

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIBODY RESPONSE; CANCER MORTALITY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HEALTH CARE ORGANIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROLOGY;

EID: 0036590563     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00161-9     Document Type: Article

References (22)

1. Nishioka K, Watanabe J, Furuta S, Tanaka E, Suzuki H, Iino S, Tsuji T, et al. Antibody to the hepatitis C virus in acute and chronic liver diseases in Japan. Liver 1991;11:65-70.
2. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-33.
3. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, et al. Hepatitis C and Hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
4. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Katayama K, Fusamoto H, Kamada K. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992;37:65-72.
5. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 1994;74:2234-8.
6. Watanabe J, Matsumoto C, Fujimura. T, Shimada H, Yoshizawa H, Okamoto H, Iizuka, et al. Predictive value of screening tests for persistent hepatitis C virus infection evidence by viraemia. Vox Sang 1993;65:199-203.
7. Health and Welfare Statistics Association. Trend of national public health. Kosei-no-Shihyo 1997;44:433-4 in Japanese.
8. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare. ed. Age-Adjusted Death Rates by Prefecture. Special Report on Vital Statistics. Kousei Toukei Kyoukai 1992: 100-103 (in Japanese).
9. Setoguchi Y, Yamamoto K, Ozaki I, Fujio N, Kariya T, Sakai T, Fujii S, et al. Prevalence of chronic liver disease and anti-HCV antibodies in different districts of Saga, Japan. Gastroenterologia Japonica 1991;26:157-61.
10. Iino S, Koike K, Yasuda K, Hino K, Sainokami S, Suzuki H, Akahane K, et al. Passive hemagglutination (PHA) second generation assay system for HCV related antibody. Prog Med 1991;11:1911-21.
11. Ito S, Ito M, Cho M, Shimotono K, Tajima K. Massive seroepidemiological study of hepatitis C virus: clustering of carriers on the southwest coast of Tsushima Japan. Jpn J Cancer Res 1991;82:1-3.
12. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabe K, Furuta K, Imai H, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994;106:1596-602.
13. Mori M, Inutsuka H, Wada I, Yamamoto K, Honda M, Naramoto J. Factors associated with hepatitis C virus transmission in an area of high incidence of hepatic cancer in Japan. Hepatol Res 1998;10:17-26.
14. Hara T, Setoguchi Y, Kajihara S, et al. Phylogenctic tree-based epidemiological analysis of hepatitis C virus transmission in a region of Japan with a high prevalence of infection. J Gastroenterol Hepatol 1996; 11:641-5.
15. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of Hepatitis C virus infection in the United States, 1988 through 1994. New Engl J Med 1999;341:556-62.
16. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
17. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota H, Chayama K, Kunada H, Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis. A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
18. Chiba T, Matsuzaki Y, Abei M, Shaoda J, Tanaka N, Osuga T, Aikawa T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996;91:1195-203.
19. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma. A case-control study in Italy. Hepatology 1997;26:579-84.
20. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993;53:790-4.
21. Yuan JM, Ross RK, Stanczyk FZ, Govindarajan S, Gao YT, Hendarson BE, Yu MC. A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer 1995;63:491-3.
22. Mori M, Hara M, Yamamoto K, Hara T, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-9.